Since its inception in 2000, The Michael J. Fox Foundation (MJFF) has funded $6.5 million in Parkinson’s disease (PD) research...

Yervoy, the first FDA approved drug for metastatic melanoma, hit the market during the past year with first quarter sales...

Healthcare companies targeting the Arab world may be surprised to discover that the best point of entry may be through...

Israeli researchers working on technology that contributes to public health, especially to that of the elderly population, can receive assistance...

A new monoclonal antibody-based drug development company brings a fresh technological approach and ambitious business model to the Israeli biotech...

Israel leads the world in the number of cardio-vascular medical device companies, said Prof. Rafael Beyar in a presentation at...

Support for 15 UK-Israel research projects was announced at  the first UK-Israel Regenerative Medicine Conference at Ben-Gurion University of the...

More than 250 members of Israel’s life sciences industry have signed a petition opposing the proposed merger of the Israeli...

While heading the Israeli company, Mindset BioPharmaceuticals, Dr. Daniel Chain developed a drug compound known as OX1. The drug has now resulted...

Increasing collaborations between Israeli and UK  biomed companies is the goal of the new High-Tech Hub recently launched in Tel...

Technology to protect mucosal membranes from pathogens such as pollen, viruses and  bacterium was presented at  this year’s Bio-Europe conference...

Photos by  a  researcher from the  Israel Institute for Biological Research have drawn large crowds at exhibits in New York,...